El Paso to begin administering second COVID-19 boosters

EL PASO, TX – Following the Food and Drug Administration’s (FDA) announcement of the authorization of a fourth dose of COVID-19, the City of El Paso announced that it will be providing second boosters to people over 50 years of age or those who are immunocompromised.

The City of El Paso reported that immunocompromised persons include those with a number of conditions, such as organ or stem cell transplant recipients, persons with advanced or untreated HIV infection, patients undergoing active treatment for cancer, or who are taking medications that weaken the immune system, among others.

A second booster dose of Pfizer or Moderna’s COVID-19 vaccine may be administered to persons 50 years of age and older who received their first booster four months ago.

The City of El Paso indicated that the second booster of the Pfizer vaccine may be given to children 12 years of age and older who have comorbidities and who received their first booster four months earlier.

Second booster doses of the Moderna vaccine can be administered to immunocompromised persons over 18 years of age, also four months after receiving the first booster. Adults who received a primary vaccine and a booster of the Johnson & Johnson vaccine four months ago are also candidates for a dose of mRNA.

The FDA previously authorized a single booster dose for certain immunocompromised individuals after completing a primary vaccination series of three vaccines. According to U.S. health officials, the move will make a second booster dose of these vaccines available to other populations at increased risk of severe illness, hospitalization and death.

Source: MEXICONOW Staff